CARMA1 is required for Akt-mediated NF-κB activation in T cells

被引:60
|
作者
Narayan, P [1 ]
Holt, B [1 ]
Tosti, R [1 ]
Kane, LP [1 ]
机构
[1] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15261 USA
关键词
D O I
10.1128/MCB.26.6.2327-2336.2006
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Many details of the generic pathway for induction of NF-kappa B have been delineated, but it is still not clear how multiple, diverse receptor systems are able to converge on this evolutionarily conserved family of transcription factors. Recent studies have shown that the CARMA1, Bcl10, and MALT1 proteins are critical for coupling the common elements of the NF-kappa B pathway to the T-cell receptor (TCR) and CD28. We previously demonstrated a role for the serine/threonine kinase Akt in CD28-mediated NF-kappa B induction. Using a CARMA1-deficient T-cell line, we have now found that the CARMA complex is required for induction of NF-kappa B by Akt, in cooperation with protein kinase C activation. Furthermore, using a novel selective inhibitor of Akt, we confirm that Akt plays a modulatory role in NF-kappa B induction by the TCR and CD28. Finally, we provide evidence for a physical and functional interaction between Akt and CARMA and for Akt-dependent phosphorylation of Bcl10. Therefore, in T cells, Akt impinges upon NF-kappa B signaling through at least two separate mechanisms.
引用
收藏
页码:2327 / 2336
页数:10
相关论文
共 50 条
  • [21] MALT1/paracaspase is a signaling component downstream of CARMA1 and mediates T cell receptor-induced NF-κB activation
    Che, TJ
    You, Y
    Wang, DH
    Tanner, MJ
    Dixit, VM
    Lin, X
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (16) : 15870 - 15876
  • [22] TCR signaling to NF-κB and mTORC1: Expanding roles of the CARMA1 complex
    Shi, Jian-hong
    Sun, Shao-Cong
    MOLECULAR IMMUNOLOGY, 2015, 68 (02) : 546 - 557
  • [23] CARMA1 is a critical lipid raft-associated regulator of TCR-induced NF-κB activation
    Gaide, O
    Favier, B
    Legler, DF
    Bonnet, D
    Brissoni, B
    Valitutti, S
    Bron, C
    Tschopp, J
    Thome, M
    NATURE IMMUNOLOGY, 2002, 3 (09) : 836 - 843
  • [24] T cell receptor/CARMA1/NF-κB signaling controls T-helper (Th) 17 differentiation
    Molinero, Luciana L.
    Cubre, Alan
    Mora-Solano, Carolina
    Wang, Ying
    Alegre, Maria-Luisa
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (45) : 18529 - 18534
  • [25] Carma1 and MALT1 are required for stimulation-dependent mTORC1 activation in T cells
    Hamilton, Kristia
    Shiva, Sruti
    Kane, Lawrence
    JOURNAL OF IMMUNOLOGY, 2014, 192
  • [26] MAGUK-Controlled Ubiquitination of CARMA1 Modulates Lymphocyte NF-κB Activity
    Moreno-Garcia, Miguel E.
    Sommer, Karen
    Shinohara, Hisaaki
    Bandaranayake, Ashok D.
    Kurosaki, Tomohiro
    Rawlings, David J.
    MOLECULAR AND CELLULAR BIOLOGY, 2010, 30 (04) : 922 - 934
  • [27] TCR-induced NF-κB activation:: a crucial role for Carma1, Bcl10 and MALT1
    Thome, M
    Tschopp, J
    TRENDS IN IMMUNOLOGY, 2003, 24 (08) : 419 - 424
  • [28] Retraction Note: NF-κB activation by Helicobacter pylorirequires Akt-mediated phosphorylation of p65
    Eriko Takeshima
    Koh Tomimori
    Hirochika Kawakami
    Chie Ishikawa
    Shigeki Sawada
    Mariko Tomita
    Masachika Senba
    Fukunori Kinjo
    Hitomi Mimuro
    Chihiro Sasakawa
    Jiro Fujita
    Naoki Mori
    BMC Microbiology, 11
  • [29] Protein Kinase C-δ Negatively Regulates T Cell Receptor-induced NF-κB Activation by Inhibiting the Assembly of CARMA1 Signalosome
    Liu, Yu
    Song, Ren
    Gao, Yan
    Li, Yi
    Wang, Shuai
    Liu, Hai-Yun
    Wang, Yan
    Hu, Yun-Hong
    Shu, Hong-Bing
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (24) : 20081 - 20087
  • [30] Oncogenic CARMA1 couples NF-κB and β-catenin signaling in diffuse large B-cell lymphomas
    Bognar, M. K.
    Vincendeau, M.
    Erdmann, T.
    Seeholzer, T.
    Grau, M.
    Linnemann, J. R.
    Ruland, J.
    Scheel, C. H.
    Lenz, P.
    Ott, G.
    Lenz, G.
    Hauck, S. M.
    Krappmann, D.
    ONCOGENE, 2016, 35 (32) : 4269 - 4281